Exchange: NASDAQ·Updated 07:34 PM EDT
News
all
press releases
FTRE vs. ARGX: Which Stock Is the Better Value Option?
FTRE vs. ARGX: Which Stock Is the Better Value Option?
Zacks
More News
Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?
Here is how argenex SE (ARGX) and Agilent Technologies (A) have performed compared to their sector so far this year.
Zacks
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Forte Biosciences, Inc. (NasdaqCM: FBRX) to argenx SE (NasdaqGS: ARGX). Under the terms of the proposed transaction, shareholders of Forte will...
Business Wire
Futures Jump As Brent Tumbles Below $90 On Fresh Round Of Iran Ceasefire Optimism
Futures Jump As Brent Tumbles Below $90 On Fresh Round Of Iran Ceasefire Optimism A sharp drop in oil prices prompted by a quieter weekend for geopolitics and a pause in?MidEast hostilities also sparked a drop in bond yields and the USD. A?powerful relief rally in stocks and bonds...
Zero Hedge
FBRX Stock On Track For Highest Levels In Over 4.5 Years As ArgenX Scoops Up Autoimmune Drug Maker
ArgenX’s acquisition of Forte Biosciences will add to its immunology portfolio, complementing existing autoimmune and neuromuscular disease therapies.
Stocktwits
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline
argenx (Euronext & Nasdaq: ARGX), a global immunology innovation company, and Forte Biosciences, Inc. (Nasdaq: FBRX) today announced that the companies have entered into a definitive agreement under which argenx will acquire Forte Biosciences for $77 per share in cash, representing a total equity...
Business Wire
Are Medical Stocks Lagging Argenx (ARGX) This Year?
Here is how argenex SE (ARGX) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Zacks
FTRE or ARGX: Which Is the Better Value Stock Right Now?
FTRE vs. ARGX: Which Stock Is the Better Value Option?
Zacks
TGTX Rises on Positive Phase I Data for Subcutaneous Briumvi in MG
TG Therapeutics gains after positive phase I data for subcutaneous Briumvi in myasthenia gravis or MG, while a phase II study in MG gets underway.
Zacks
ARGX Shares Gain Nearly 9% in a Month: Here's What You Need to Know
argenx stock rises nearly 9% in a month after the FDA expands Vyvgart's gMG label, opening treatment to adult patients regardless of antibody status.
Zacks
<
1
2
>

Advertisement|Remove ads.